Name: Clear Cell Renal Cell Carcinoma 2021-2022 (en Inglés)
Price: 83740.00 CLP
Availability: InStock
Author: Manini, Claudia ; López, José I.
ISBN: 9783036555171

portada Clear Cell Renal Cell Carcinoma 2021-2022 (en Inglés)

Formato

Libro Físico

Editorial

Mdpi AG

Autor

Manini, Claudia ; López, José I.

Idioma

Inglés

N° páginas

342

Encuadernación

Tapa Dura

Dimensiones

24.4 x 17.0 x 2.7 cm

Peso

0.93 kg.

ISBN13

9783036555171

Categorías

Farmacología

Clear Cell Renal Cell Carcinoma 2021-2022 (en Inglés)

Manini, Claudia ; López, José I. (Autor) · Mdpi AG · Tapa Dura

Libro Nuevo

$ 83.740

$ 167.480

Ahorras: $ 83.740

50% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Jueves 11 de Julio y el Martes 23 de Julio.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Clear Cell Renal Cell Carcinoma 2021-2022 (en Inglés)"

Clear cell renal cell carcinoma is currently one of the most interesting areas of study in oncology. Despite the advances made in this field, this tumor continues to be a health problem of major concern in Western societies, seriously affecting public health services. Several characteristics of this tumor make it an exciting meeting point for translational collaboration between clinicians and basic researchers.Clear cell renal cell carcinoma is a paradigmatic example of inter- and intra-tumor heterogeneity from morphological, immunohistochemical, and molecular viewpoints. This tumor is also a good example to investigate the complexity of tumor/tumor and tumor/environment relationships from an ecological perspective. A deeper identification of the varied internal tumor self-organization through the specialization of cell clones and subclones as local invaders and metastasizers, on one hand, and the interactions of specific subsets of tumor cells with the local host microenvironment, on the other, will significantly enrich our knowledge of this neoplasm.Clear cell renal cell carcinoma is also a paradigmatic test bench for antiangiogenic and immune checkpoint blockage therapies. The refinement of these therapeutic tools administered alone or in combination is a hot issue in oncology, and several international trials are underway.